Showing 1 - 10 of 4,174
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members − except least-developed country members (LDCs) - to … to be compliant with this provision of TRIPS by 2005. This study investigates two questions in this context: (1) How does …
Persistent link: https://www.econbiz.de/10011992779
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...
Persistent link: https://www.econbiz.de/10011509446
Persistent link: https://www.econbiz.de/10011925529
Persistent link: https://www.econbiz.de/10011563305
Persistent link: https://www.econbiz.de/10012433548
Persistent link: https://www.econbiz.de/10012433661
Persistent link: https://www.econbiz.de/10012433977
Persistent link: https://www.econbiz.de/10010419020
Fehlende Medikamente zur Bekämpfung armutsassoziierter Krankheiten sind ein globales Gesundheitsproblem.Katrin Gerlinger stellt in diesem Band Initiativen öffentlicher, gemeinnütziger und privater Akteure zur Stärkung der Produktentwicklung vor und nennt politische Optionen zur Förderung...
Persistent link: https://www.econbiz.de/10012015246
Persistent link: https://www.econbiz.de/10012433673